Tapewire

Nasdaq · USD

ARQT

Arcutis Biotherapeutics, Inc.

Export transactions ↓
Tapewire entity
4236
SEC CIK
0001787306
Parsed reports
442

Last 12 months

Inside the activity.

0 purchase rows · 76 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025019
Dec 202505
Jan 202602
Feb 2026011
Mar 2026013
Apr 202601
May 202608
Jun 202603
Jul 202601
Aug 2026010
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 12, 2024 Filed Jan 17, 2024 21:34 UTC
Edwards Larry ToddChief Commercial Officer
GrantStock Option (right to buy) · Derivative 176,000 $0.00 Strike: $3.64 $0.00
Disclosure

SEC source: 0001787306-24-000010 · wk-form4_1705527248.xml · derivative · entry 2

Edwards Larry Todd · CIK 0001994805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 176,000

Underlying: Common Stock · 176,000 shares

Expires 2034-01-12

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:34 UTC
Edwards Larry ToddChief Commercial Officer
GrantCommon Stock 28,000 $0.00 $0.00
Disclosure

SEC source: 0001787306-24-000010 · wk-form4_1705527248.xml · nonDerivative · entry 1

Edwards Larry Todd · CIK 0001994805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,000

F1 · shares: Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:30 UTC
Watanabe ToddDirector · See Remarks
GrantStock Option (right to buy) · Derivative 410,000 $0.00 Strike: $3.64 $0.00
Disclosure

SEC source: 0001787306-24-000006 · wk-form4_1705527025.xml · derivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 410,000

Underlying: Common Stock · 410,000 shares

Expires 2034-01-12

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:30 UTC
Watanabe ToddDirector · See Remarks
GrantCommon Stock 125,000 $0.00 $0.00
Disclosure

SEC source: 0001787306-24-000006 · wk-form4_1705527025.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 627,019

F1 · shares: Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:28 UTC
Moore Matthew RichardSVP and Chief Business Officer
GrantStock Option (Right to Buy) · Derivative 126,000 $0.00 Strike: $3.64 $0.00
Disclosure

SEC source: 0001787306-24-000004 · wk-form4_1705526921.xml · derivative · entry 2

Moore Matthew Richard · CIK 0001840191 · SVP and Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,000

Underlying: Common Stock · 126,000 shares

Expires 0034-01-12

F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from January 12, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer.

Read SEC document
January 12, 2024 Filed Jan 17, 2024 21:28 UTC
Moore Matthew RichardSVP and Chief Business Officer
GrantCommon Stock 28,000 $0.00 $0.00
Disclosure

SEC source: 0001787306-24-000004 · wk-form4_1705526921.xml · nonDerivative · entry 1

Moore Matthew Richard · CIK 0001840191 · SVP and Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,590

F1 · shares: Constitute Restricted Stock Units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon vesting. 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year, beginning on February 1, 2025, subject to the Reporting Person's continued service to the issuer.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 22:30 UTC
Burnett PatrickSee Remarks
SaleCommon Stock 1,325 $3.54 $4,691.56
Disclosure

SEC source: 0001787306-24-000002 · wk-form4_1704321036.xml · nonDerivative · entry 1

Burnett Patrick · CIK 0001741987 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,032

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
December 20, 2023 Filed Dec 22, 2023 22:24 UTC
Watanabe ToddDirector · See Remarks
GiftCommon Stock 6,563 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000134 · wk-form4_1703283856.xml · nonDerivative · entry 4

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 24,413

F2 · ownership.nature: The securities are held of record by The John Franklin Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.

Read SEC document
December 20, 2023 Filed Dec 22, 2023 22:24 UTC
Watanabe ToddDirector · See Remarks
GiftCommon Stock 6,563 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000134 · wk-form4_1703283856.xml · nonDerivative · entry 3

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By Trust

Disclosed balance after: 24,413

F1 · ownership.nature: The securities are held of record by The Anderson Prest Watanabe Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person and members of his immediate family are the sole beneficiaries of the trust.

Read SEC document
December 20, 2023 Filed Dec 22, 2023 22:24 UTC
Watanabe ToddDirector · See Remarks
GiftCommon Stock 6,563 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000134 · wk-form4_1703283856.xml · nonDerivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 502,019

Read SEC document
December 20, 2023 Filed Dec 22, 2023 22:24 UTC
Watanabe ToddDirector · See Remarks
GiftCommon Stock 6,563 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000134 · wk-form4_1703283856.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508,582

Read SEC document
December 01, 2023 Filed Dec 2, 2023 01:51 UTC
Watanabe ToddDirector · See Remarks
Exercise / conversionStock Option (right to buy) · Derivative 59,525 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001787306-23-000129 · wk-form4_1701481885.xml · derivative · entry 7

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,823

Underlying: Common Stock · 59,525 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

F1 · derivative.exercise_date: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
December 01, 2023 Filed Dec 2, 2023 01:51 UTC
Watanabe ToddDirector · See Remarks
Exercise / conversionCommon Stock 59,525 $1.68 $100,037.72
Disclosure

SEC source: 0001787306-23-000129 · wk-form4_1701481885.xml · nonDerivative · entry 1

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 513,682

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option began vesting monthly over a four year period beginning upon the achievement of certain company milestones, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
November 21, 2023 Filed Nov 21, 2023 22:47 UTC
Matsuda MasaruSee Remark
SaleCommon Stock 1,850 $1.98 $3,661.15
Disclosure

SEC source: 0001787306-23-000126 · wk-form4_1700606852.xml · nonDerivative · entry 2

Matsuda Masaru · CIK 0001798679 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,634

F2 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable tax withholdings.

F3 · price: The transaction was executed in multiple trade in prices ranging from $1.965 to $1.98, inclusive. The price reported in Column 4 reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 18, 2023 Filed Nov 21, 2023 22:47 UTC
Matsuda MasaruSee Remark
GrantCommon Stock 4,875 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000126 · wk-form4_1700606852.xml · nonDerivative · entry 1

Matsuda Masaru · CIK 0001798679 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,484

F1 · shares: Represents performance stock units ("PSUs") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on November 18, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date.

Read SEC document
October 24, 2023 Filed Oct 26, 2023 20:09 UTC
Heron Patrick JDirector · 10% owner
PurchaseCommon Stock 80,000 $2.50 $200,000.00
Disclosure

SEC source: 0001209191-23-053662 · doc4.xml · nonDerivative · entry 1

Frazier Life Sciences VIII, L.P. · CIK 0001655827 · 10% owner

FHM LIFE SCIENCES VIII, L.P. · CIK 0001698755 · 10% owner

FHM LIFE SCIENCES VIII, L.L.C. · CIK 0001698823 · 10% owner

Topper James N · CIK 0001341382 · 10% owner

Heron Patrick J · CIK 0001365617 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,764,232

Read SEC document
September 27, 2023 Filed Oct 4, 2023 01:45 UTC
Edwards Larry ToddChief Commercial Officer
GrantStock Option (right to buy) · Derivative 240,000 $0.00 Strike: $5.58 $0.00
Disclosure

SEC source: 0001787306-23-000113 · wk-form4_1696383903.xml · derivative · entry 2

Edwards Larry Todd · CIK 0001994805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 240,000

Underlying: Common Stock · 240,000 shares

Expires 2033-09-27

F2 · derivative.exercise_date: The option will vest and become exercisable as to 25% of the shares subject to the option on October 1, 2024, and the remaining options will vest at 2.0833% subject to the options on each monthly anniversary thereafter, subject to Reporting Person's continued service through the applicable vesting date.

Read SEC document
September 27, 2023 Filed Oct 4, 2023 01:45 UTC
Edwards Larry ToddChief Commercial Officer
GrantCommon Stock 60,000 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000113 · wk-form4_1696383903.xml · nonDerivative · entry 1

Edwards Larry Todd · CIK 0001994805 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

F1 · shares: The Restricted Stock Units ("RSUs") will vest as to 25% of the RSUs on each annual anniversary of October 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date.

Read SEC document
August 31, 2023 Filed Sep 6, 2023 01:38 UTC
Smither John WChief Financial Officer
GrantStock Option (right to buy) · Derivative 125,000 $0.00 Strike: $8.54 $0.00
Disclosure

SEC source: 0001787306-23-000088 · wk-form4_1693964312.xml · derivative · entry 1

Smither John W · CIK 0001559583 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2033-08-31

F1 · derivative.exercise_date: The option vests 1/48 of the total shares in equal monthly installments over a four year period, beginning September 30, 2023, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
August 29, 2023 Filed Sep 12, 2023 11:39 UTC
Moore Matthew RichardSVP and Chief Business Officer
GrantStock Option (Right to Buy) · Derivative 12,500 $0.00 Strike: $28.72 $0.00
Disclosure

SEC source: 0001787306-23-000092 · wk-form4_1694518782.xml · derivative · entry 1

Moore Matthew Richard · CIK 0001840191 · SVP and Chief Business Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2031-01-18

F1 · shares: 1/48th of the shares vest on each monthly anniversary of the milestone vesting commencement date, beginning on September 29, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F1 · derivative.exercise_date: 1/48th of the shares vest on each monthly anniversary of the milestone vesting commencement date, beginning on September 29, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
August 21, 2023 Filed Aug 22, 2023 16:24 UTC
Burnett PatrickSee Remarks
SaleCommon Stock 1,305 $7.04 $9,187.20
Disclosure

SEC source: 0001787306-23-000083 · wk-form4_1692721462.xml · nonDerivative · entry 2

Burnett Patrick · CIK 0001741987 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,357

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
August 21, 2023 Filed Aug 22, 2023 16:24 UTC
Burnett PatrickSee Remarks
SaleCommon Stock 300 $7.05 $2,115.00
Disclosure

SEC source: 0001787306-23-000083 · wk-form4_1692721462.xml · nonDerivative · entry 1

Burnett Patrick · CIK 0001741987 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,662

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based Restricted Stock Units ("RSUs"), granted on August 3, 2020. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:59 UTC GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000052 · wk-form4_1685746757.xml · derivative · entry 2

Krishnamohan Neha · CIK 0001866171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:59 UTC GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000052 · wk-form4_1685746757.xml · nonDerivative · entry 1

Krishnamohan Neha · CIK 0001866171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,607

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:31 UTC
Matsuda MasaruSee Remark
GrantCommon Stock 1,463 $6.38 $9,333.94
Disclosure

SEC source: 0001787306-23-000066 · wk-form4_1685752267.xml · nonDerivative · entry 3

Matsuda Masaru · CIK 0001798679 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,609

F4 · kind: Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
May 31, 2023 Filed Jun 3, 2023 00:31 UTC
Matsuda MasaruSee Remark
SaleCommon Stock 1,830 $7.80 $14,278.21
Disclosure

SEC source: 0001787306-23-000066 · wk-form4_1685752267.xml · nonDerivative · entry 2

Matsuda Masaru · CIK 0001798679 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,146

F2 · kind: Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the PSUs, the shares were sold upon the vesting of the PSUs solely to cover applicable withholding taxes.

F3 · price: The transaction was executed in multiple trades in prices ranging from $7.79 to $7.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:10 UTC GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000058 · wk-form4_1685747445.xml · derivative · entry 2

Curran Terrie · CIK 0001690298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:10 UTC GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000058 · wk-form4_1685747445.xml · nonDerivative · entry 1

Curran Terrie · CIK 0001690298 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,687

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:13 UTC GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000060 · wk-form4_1685747612.xml · derivative · entry 3

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:13 UTC GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000060 · wk-form4_1685747612.xml · nonDerivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 850,078

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:02 UTC GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000054 · wk-form4_1685746945.xml · derivative · entry 3

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:02 UTC GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000054 · wk-form4_1685746945.xml · nonDerivative · entry 1

Leonard Keith R · CIK 0001416180 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,687

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:16 UTC
Heron Patrick JDirector · 10% owner
GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000062 · wk-form4_1685747781.xml · derivative · entry 2

Heron Patrick J · CIK 0001365617 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:16 UTC
Heron Patrick JDirector · 10% owner
GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000062 · wk-form4_1685747781.xml · nonDerivative · entry 1

Heron Patrick J · CIK 0001365617 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,687

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:08 UTC GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000056 · wk-form4_1685747268.xml · derivative · entry 2

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:08 UTC GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000056 · wk-form4_1685747268.xml · nonDerivative · entry 1

Gilbert Halley E · CIK 0001601360 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,687

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:22 UTC
LIN SUE-JEANDirector
GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000064 · wk-form4_1685748130.xml · derivative · entry 2

LIN SUE-JEAN · CIK 0001867788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F2 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 23:22 UTC
LIN SUE-JEANDirector
GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000064 · wk-form4_1685748130.xml · nonDerivative · entry 1

LIN SUE-JEAN · CIK 0001867788 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,987

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:54 UTC GrantStock Option (right to buy) · Derivative 12,220 $0.00 Strike: $7.51 $0.00
Disclosure

SEC source: 0001787306-23-000050 · wk-form4_1685746466.xml · derivative · entry 3

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,220

Underlying: Common Stock · 12,220 shares

Expires 2033-05-31

F3 · derivative.exercise_date: The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 22:54 UTC GrantCommon Stock 4,375 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000050 · wk-form4_1685746466.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,200

F1 · balance_after: Includes 4,375 Restricted Stock Units (?RSUs?). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

Read SEC document
May 31, 2023 Filed Dec 2, 2023 01:51 UTC
Watanabe ToddDirector · See Remarks
PurchaseCommon Stock 1,463 $6.38 $9,333.94
Disclosure

SEC source: 0001787306-23-000129 · wk-form4_1701481885.xml · nonDerivative · entry 2

Watanabe Todd Franklin · CIK 0001801061 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,145

F2 · kind: Pursuant to the purchase transaction of the Company's Employee Stock Purchase plan.

Read SEC document
May 27, 2023 Filed Jun 3, 2023 00:31 UTC
Matsuda MasaruSee Remark
GrantCommon Stock 4,875 $0.00 $0.00
Disclosure

SEC source: 0001787306-23-000066 · wk-form4_1685752267.xml · nonDerivative · entry 1

Matsuda Masaru · CIK 0001798679 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,976

F1 · shares: Represents Performance Stock Units ("PSUs") initially granted on January 3, 2022, that were subject to a performance-based vesting condition. The vesting condition was determined to be satisfied on May 27, 2022. The PSUs will vest fully on May 27, 2025, subject to the Reporting Person's continued service to the Issuer on such vesting date.

Read SEC document
April 17, 2023 Filed Apr 18, 2023 23:00 UTC Exercise / conversionStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001787306-23-000036 · wf-form4_168185882846729.xml · derivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,458

Underlying: Common Stock · 8,500 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 17, 2023 Filed Apr 18, 2023 23:00 UTC SaleCommon Stock 8,500 $13.97 $118,728.00
Disclosure

SEC source: 0001787306-23-000036 · wf-form4_168185882846729.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,825

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.76 to $14.20, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 17, 2023 Filed Apr 18, 2023 23:00 UTC Exercise / conversionCommon Stock 8,500 $1.68 $14,285.10
Disclosure

SEC source: 0001787306-23-000036 · wf-form4_168185882846729.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 06, 2023 Filed Apr 10, 2023 20:13 UTC Exercise / conversionStock Option (right to buy) · Derivative 8,500 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001787306-23-000027 · wf-form4_168115758269324.xml · derivative · entry 4

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,958

Underlying: Common Stock · 8,500 shares

Expires 2029-03-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F4 · derivative.exercise_date: The option began vesting on March 13, 2019 and will vest monthly over a four year period, subject to the Reporting Person's continuous provision of services to the Issuer on each vesting date. The option contains an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.

Read SEC document
April 06, 2023 Filed Apr 10, 2023 20:13 UTC SaleCommon Stock 8,500 $12.01 $102,085.00
Disclosure

SEC source: 0001787306-23-000027 · wf-form4_168115758269324.xml · nonDerivative · entry 2

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,825

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.035, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
April 06, 2023 Filed Apr 10, 2023 20:13 UTC Exercise / conversionCommon Stock 8,500 $1.68 $14,285.10
Disclosure

SEC source: 0001787306-23-000027 · wf-form4_168115758269324.xml · nonDerivative · entry 1

Welgus Howard G. · CIK 0001801050 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 174,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 21:29 UTC
Burrows Scott LChief Financial Officer
SaleCommon Stock 291 $15.26 $4,441.65
Disclosure

SEC source: 0001567619-23-004671 · doc1.xml · nonDerivative · entry 1

Burrows Scott L · CIK 0001853327 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,115

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: The transaction was executed in multiple trades in prices ranging from $15.120 to $15.440, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 16:26 UTC
OSBORNE DAVID WChief Technical Officer
SaleCommon Stock 690 $15.26 $10,531.75
Disclosure

SEC source: 0001567619-23-004668 · doc1.xml · nonDerivative · entry 1

OSBORNE DAVID W · CIK 0001252999 · Chief Technical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 268,854

F1 · kind: The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

F2 · price: The transaction was executed in multiple trades in prices ranging from $15.120 to $15.440, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.